| Click-ExM enables expansion microscopy for all biomolecules D Sun, X Fan, Y Shi, H Zhang, Z Huang, B Cheng, Q Tang, W Li, Y Zhu, ... Nature Methods 18 (1), 107-113, 2021 | 144 | 2021 |
| Next-generation unnatural monosaccharides reveal that ESRRB O-GlcNAcylation regulates pluripotency of mouse embryonic stem cells Y Hao, X Fan, Y Shi, C Zhang, D Sun, K Qin, W Qin, W Zhou, X Chen Nature communications 10 (1), 4065, 2019 | 118 | 2019 |
| Detecting Tumor Antigen-Specific T Cells via Interaction-Dependent Fucosyl-Biotinylation Z Liu, JP Li, M Chen, M Wu, Y Shi, W Li, JR Teijaro, P Wu Cell 183 (4), 1117-1133. e19, 2020 | 103 | 2020 |
| Glycoengineering of NK Cells with Glycan Ligands of CD22 and Selectins for B‐Cell Lymphoma Therapy S Hong, C Yu, P Wang, Y Shi, W Cao, B Cheng, DG Chapla, Y Ma, J Li, ... Angewandte Chemie International Edition 60 (7), 3603-3610, 2021 | 57 | 2021 |
| Bacterial glycosyltransferase-mediated cell-surface chemoenzymatic glycan modification S Hong, Y Shi, NC Wu, G Grande, L Douthit, H Wang, W Zhou, ... Nature communications 10 (1), 1799, 2019 | 51 | 2019 |
| Modulation of Siglec-7 Signaling Via In Situ-Created High-Affinity cis-Ligands S Hong, C Yu, E Rodrigues, Y Shi, H Chen, P Wang, DG Chapla, T Gao, ... ACS central science 7 (8), 1338-1346, 2021 | 36 | 2021 |
| Chemoproteomic and Transcriptomic Analysis Reveals that O‐GlcNAc Regulates Mouse Embryonic Stem Cell Fate through the Pluripotency Network Y Hao, X Li, K Qin, Y Shi, Y He, C Zhang, B Cheng, X Zhang, G Hu, ... Angewandte Chemie 135 (17), e202300500, 2023 | 12 | 2023 |
| Targeted desialylation and cytolysis of tumour cells by fusing a sialidase to a bispecific T-cell engager Z Yang, Y Hou, G Grande, JH Cho, C Wang, Y Shi, J Zak, Y Wan, K Qin, ... Nature Biomedical Engineering, 1-14, 2024 | 7 | 2024 |
| Transient EZH2 Suppression by Tazemetostat during In Vitro Expansion Maintains T-Cell Stemness and Improves Adoptive T-Cell Therapy Y Hou, J Zak, Y Shi, I Pratumchai, B Dinner, W Wang, K Qin, EW Weber, ... Cancer Immunology Research 13 (1), 47-65, 2025 | 4 | 2025 |
| Enhancing the anti-tumor efficacy of Bispecific T cell engagers via cell surface glycocalyx editing Z Yang, Y Hou, G Grande, C Wang, Y Shi, J Zak, JH Cho, D Liu, ... bioRxiv, 2022.05. 22.492978, 2022 | 3 | 2022 |
| Chemical immunology: Recent advances in tool development and applications Y Shi, EE Bashian, Y Hou, P Wu Cell Chemical Biology, 2024 | 1 | 2024 |
| Bacterial Glycosyltransferase-mediated Cell-surface Chemoenzymatic Glycan Editing: Methods and Applications S Hong, Y Shi, NC Wu, G Grande, L Douthit, IA Wilson, J Xie, P Wu bioRxiv, 322461, 2018 | 1 | 2018 |
| Reshaping the tumor microenvironment by degrading glycoimmune checkpoints Siglec-7 and-9 C Wang, Y Hou, J Zak, Q Zheng, KA McCord, M Wu, D Zhang, S Chung, ... bioRxiv, 2024.10. 11.617879, 2024 | | 2024 |
| Detecting Tumor Specific Antigen-Reactive T cells from Tumor Infiltrating Lymphocytes via Interaction Dependent Fucosyl-biotinylation Z Liu, JP Li, M Chen, M Wu, Y Shi, W Li, JR Teijaro, P Wu bioRxiv, 2020.03. 18.996017, 2020 | | 2020 |
